Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Updated

Jan. 01, 2020

Reviewed

Aug. 01, 2019

Appendix B: Panel Roster and Financial Disclosures

Community-Acquired Pneumonia

Community-Acquired Pneumonia
Member		Financial Disclosure
Member		Company	Relationship
Cribbs, Shushma	Emory University	National Institutes of Health	Research Support
Crothers, Kristina*	University of Washington	American Lung Association	Research Support
Crothers, Kristina*	University of Washington	National Institutes of Health	Research Support
Kobayashi, Miwako	Centers for Disease Control and Prevention	None	N/A
Matanock, Almea	Centers for Disease Control and Prevention	Gavi, The Vaccine Alliance	Research Support
Miller, Robert	University College London, England	Gilead	Honoraria, Speaker’s Bureau
Miller, Robert	University College London, England	British HIV Association	Research Support
Niederman, Michael	Cornell University	Bayer	Advisory Board, Research Support
		Merck	Advisory Board, Research Support
		Partek	Advisory Board
		Pfizer	Advisory Board
		Shionogi	Advisory Board, Research Support
Rodriguez-Barradas, Maria	Michael E. DeBakey VAMC and Baylor College of Medicine	None	N/A
* Group lead Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.

Download Guidelines

Section OnlyPDF (337.79 KB)
Full GuidelinePDF (3.78 MB)
Tables OnlyPDF (481.21 KB)